Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by bfwon Jul 13, 2018 10:28pm

170 Views

Post# 28315495

RE:RE:RE:Personally,

There is is a common theme among at least 2 of those names.

1. Cyclical
2. Debt

Those comparisons are not applicable here.

bfw

antiguru wrote: If readers paid attention to the posts just before July 5 Q2 report, they would have seen who or what I referred.,suffice to say it's not SPECO1. No need to name name toher than a reminder to all that a stock's true worth will eventually prove itself. No need to mindlessly pump or bash it. I have experienced these many times...Oilexco, Bankers Petroleum, Tehara...Any cautionary dissenter is quickly run out of town and then the next thing you know all hell bresk loose.

Bullboard Posts

Soma Gold poised to extend profitable track record